AstraZeneca Enters $40 Million Drug Discovery Deal With Insitro
The collaboration will identify drug targets and develop therapeutics for MASH and cardiomyopathies. AstraZeneca will make an upfront payment of $40 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.